Skip to main content
. 2017 May 2;17:78. doi: 10.1186/s12890-017-0424-4

Table 3.

Characteristics of community-acquired pneumonia survivors and non-survivors

Survivors Non-survivors Univariate
n = 1708 n = 122 P value
Male 1187 (69.5) 92 (75.4) 0.20
Age (y) 73.2 ± 14.4 78.8 ± 10.4 <0.001
Smoking statusa 0.26
 Current 273 (16.0) 19 (15.6)
 Past 780 (45.7) 68 (55.7)
 Never 655 (38.3) 35 (28.7)
Comorbidity
 Chronic heart disease 509 (29.8) 45 (36.9) 0.12
 COPDb 393 (23.0) 46 (37.7) <0.001
 Diabetes mellitus 340 (19.9) 24 (19.7) 1.00
 Cerebrovascular disease 325 (19.0) 27 (22.1) 0.47
 Malignancy 148 (8.7) 19 (15.6) 0.02
 Chronic kidney disease 125 (7.3) 11 (9.0) 0.47
 Chronic liver disease 100 (5.9) 10 (8.2) 0.39
Vital signs
 Body temperature (°C) 37.9 ± 1.1 37.4 ± 1.2 <0.001
 Systolic blood pressure (mmHg) 129 ± 26 126 ± 30 0.19
 Heart rate (beats/min) 98 ± 19 103 ± 25 0.004
 Respiratory rate (breaths/min) 23 ± 7 28 ± 9 <0.001
 PaO2/FiO2 ≤ 250 (mmHg)c 554 (32.4) 92 (75.4) <0.001
Laboratory examinations
 Alb (g/dL) 3.2 ± 0.6 2.6 ± 0.6 <0.001
 BUN (mg/dL) 21.8 ± 14.5 34.5 ± 22.2 <0.001
 Cr (mg/dL) 1.01 ± 0.8 1.27 ± 1.2 0.001
 Na (mmol/L) 136.7 ± 4.2 137.2 ± 6.3 0.25
 Ht (%) 37.1 ± 5.5 35.6 ± 6.5 0.004
 Plt (×104/μL) 22.5 ± 10.2 22.8 ± 10.2 0.75
 WBC (×103/μL) 12.3 ± 6.2 12.1 ± 6.4 0.75
 CRP (mg/L) 125 ± 94 164 ± 108 <0.001
Multilobar pneumonia 939 (55.0) 99 (81.1) <0.001
Bacteremia 73 (4.3) 20 (16.4) <0.001
β-lactam monotherapy 1109 (64.9) 72 (59.0) 0.22
AZM combination 354 (20.7) 12 (9.8) 0.005
FQN combination 81 (4.7) 30 (24.6) <0.001
MINO combination 79 (4.6) 3 (2.5) 0.37
Mechanical ventilation 99 (5.8) 40 (32.8) <0.001
Vasopressor drug usage 60 (3.5) 26 (21.3) <0.001
ICU admission 67 (3.9) 28 (23.0) <0.001
A-DROP (score) <0.001
 0 204 (11.9) 1 (0.8)
 1 478 (28.0) 7 (5.7)
 2 545 (31.9) 28 (23.0)
 3 372 (21.8) 54 (44.3)
 4 97 (5.7) 29 (23.8)
 5 12 (0.7) 3 (2.5)
CURB-65 (score) <0.001
 0 192 (11.2) 0 (0)
 1 540 (31.6) 12 (9.8)
 2 594 (34.8) 39 (32.0)
 3 294 (17.2) 35 (28.7)
 4 74 (4.3) 32 (26.2)
 5 14 (0.8) 4 (3.3)
PSI (score) 100.7 ± 32.3 140.9 ± 37.2 <0.001
PSI (class) <0.001
 I 36 (2.1) 0 (0)
 II 210 (12.3) 1 (0.8)
 III 447 (26.2) 8 (6.6)
 IV 750 (43.9) 47 (38.5)
 V 265 (15.5) 66 (54.1)
IDSA/ATS severe criteria <0.001
 Yes 490 (28.7) 95 (77.9)
 No 1218 (71.3) 27 (22.1)

Data are presented as mean ± SD or n (%)

Abbreviations: A-DROP age ≥70 years in men or age ≥75 years in women, blood urea nitrogen ≥21 mg · dL−1 or dehydration, oxyhemoglobin saturation measured by pulse oximetry ≤90% or partial pressure of oxygen in arterial blood ≤60 mmHg, confusion, or systolic blood pressure ≤90 mmHg, Alb Albumin, ATS American Thoracic Society, AZM azithromycin, BUN Blood urea nitrogen, COPD chronic obstructive pulmonary disease, Cr Creatinine, CRP C-reactive protein, CURB-65 confusion, urea >7 mmol/L, respiratory rate ≥30 breaths/min, low blood pressure (systolic <90 mmHg or diastolic ≤60 mmHg), and age ≥65 years, FiO 2 fraction of inspired oxygen, FQN fluoroquinolone, Ht Hematocrit, ICU intensive care unit, IDSA Infectious Diseases Society of America, MINO minomycin, Na Sodium, PaO 2 partial pressure of arterial oxygen, Plt Platelet, PSI Pneumonia Severity Index, WBC white blood cell

aCurrent: Patients who are current smokers and have been smoking more than 100 cigarettes in their entire life, Past: Patients who quit smoking more than a month ago and have been smoking more than 100 cigarettes in their entire life, Never: Patients who have not smoked in the past month and have not smoked more than 100 cigarettes in their entire life.

bWe diagnosed COPD according to the GOLD definition [6]. Patients who were already diagnosed and treated as COPD in other hospitals and had emphysema on chest tomography were also included.

cArterial blood gas analyses were not performed in 513 of the survivors and 12 of the non-survivors; in these patients, arterial oxygen partial pressure was estimated from oxyhemoglobin saturation measured by pulse oximetry.